… In summary, we found that the proportion of patients with heart failure who would be
potentially eligible for CRT is much lower than the previous estimates. In our hospital discharge …

… , is more effective than enalapril for some patients with heart failure (HF). It is uncertain what
proportion of patients with HF would be eligible for sacubitril–valsartan in clinical practice. …

… Patients who need and receive timely advanced heart failure (HF) therapies have better
long-term survival. However, many of these patients are not identified and referred as soon as …

… seen in practice, the magnitude of the discrepancies in the area of heart failure on a … of
older patients surviving hospitalization with heart failure who would have been eligible for …

… In the present study, we studied a partially eligible group by combining heart failure duration
above 6 months and final achieved dose of ACEI or ARB after up-titration. We believe it is …

… Using data from Get With The Guidelines–Heart Failure between 2012 and 2015, this study
evaluated the proportion of hospitalized patients with HF who were eligible for CRT on the …

… in a clinical practice cohort of eligible heart failure patients. However, CRT technology …
Our findings support the ongoing use of CRT in eligible heart failure patients regardless of …

… Several studies in a variety of clinical settings have documented that a significant
proportion of eligible patients with HF are not receiving treatment with these guideline-recommended, …

… During site visits, monitors review compliance with the protocol and processes used to capture
data for all of the eligible patients with heart failure To preserve patient anonymity, source …

… what percentage of patients admitted for heart failure met criteria for cardiac resynchronization
therapy. METHODS: The study involved registry data on heart failure admissions at 16 …